Contact
Please use this form to send email to PR contact of this press release:
ExCellThera’s lead technology, ECT-001, receives FDA Regenerative Medicine Advanced Therapy (RMAT) designation
TO:
Please use this form to send email to PR contact of this press release:
ExCellThera’s lead technology, ECT-001, receives FDA Regenerative Medicine Advanced Therapy (RMAT) designation
TO: